taxonomy (1)
protein (1)
source (2)
structure (0)
composition (13)
disease (2)
reference (3)
site (4)
peptide (5)
- Homo sapiens (Human)
Taxonomy
Reported structure
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 (avg mass : 2516.3091 )
- Hex:6 HexNAc:4 NeuAc:1 (avg mass : 2094.9076 )
- Hex:6 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2387.1936 )
- Hex:6 HexNAc:5 NeuAc:2 (avg mass : 2589.3605 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:3 (avg mass : 3172.9044 )
- Hex:6 HexNAc:5 dHex:3 NeuAc:1 (avg mass : 2736.5316 )
- Hex:6 HexNAc:5 dHex:3 NeuAc:2 (avg mass : 3027.7895 )
Composition
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
Reference
- Hepatocyte growth factor activator / Homo sapiens
Reported glycosite
- CFLGNGTGYR (10aa)
- DSVSVVLGQHFFNR (14aa)
- DSVSVVIGQHFFNR (14aa)
- YIPYTLYSVFNPSDHDLVLIR (21aa)
- CQIAGWGHLDENVSGYSSSLR (21aa)
Mass spectrometry observed peptide
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2078.9082)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Hepatocyte growth factor activator / Homo sapiens
- CFLGNGTGYR (10aa)
-
- Hex:6 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 2094.9076)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Hepatocyte growth factor activator / Homo sapiens
- CFLGNGTGYR (10aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Hepatocyte growth factor activator / Homo sapiens
- DSVSVVLGQHFFNR (14aa)
- DSVSVVIGQHFFNR (14aa)
- YIPYTLYSVFNPSDHDLVLIR (21aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2225.0512)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Hepatocyte growth factor activator / Homo sapiens
- CFLGNGTGYR (10aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked (avg mass : 2370.1661)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Hepatocyte growth factor activator / Homo sapiens
- CFLGNGTGYR (10aa)
- CQIAGWGHLDENVSGYSSSLR (21aa)
-
- Hex:6 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2387.1936)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Hepatocyte growth factor activator / Homo sapiens
- CFLGNGTGYR (10aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 / N-Linked (avg mass : 2516.3091)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Hepatocyte growth factor activator / Homo sapiens
- CFLGNGTGYR (10aa)
-
- Hex:6 HexNAc:5 NeuAc:2 / N-Linked (avg mass : 2589.3605)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Hepatocyte growth factor activator / Homo sapiens
- YIPYTLYSVFNPSDHDLVLIR (21aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 / N-Linked (avg mass : 2735.5035)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Hepatocyte growth factor activator / Homo sapiens
- CFLGNGTGYR (10aa)
-
- Hex:6 HexNAc:5 dHex:3 NeuAc:1 / N-Linked (avg mass : 2736.5316)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Hepatocyte growth factor activator / Homo sapiens
- CFLGNGTGYR (10aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 / N-Linked (avg mass : 3026.7614)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Hepatocyte growth factor activator / Homo sapiens
- CFLGNGTGYR (10aa)
-
- Hex:6 HexNAc:5 dHex:3 NeuAc:2 / N-Linked (avg mass : 3027.7895)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Hepatocyte growth factor activator / Homo sapiens
- CFLGNGTGYR (10aa)
-
- Hex:6 HexNAc:5 dHex:2 NeuAc:3 / N-Linked (avg mass : 3172.9044)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Hepatocyte growth factor activator / Homo sapiens
- CFLGNGTGYR (10aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
